An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT03759288 · TERMINATED
Trial details
- NCT number
- NCT03759288
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-07
- Primary completion
- 2023-10-18
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.